Measuring respiratory outcome

Seminars in Neonatology

Volumn 5, Issue 2, 2000, Pages 119-126

  Greenough, Anne ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Airway hyperreactivity; Bronchopulmonary dysplasia; Chronic lung disease of prematurity; Prematurity; Very low birthweight

Indexed keywords

CHRONIC LUNG DISEASE; DISEASE ASSOCIATION; HUMAN; INFANT; LUNG DYSPLASIA; NEWBORN MORBIDITY; PREMATURITY; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VERY LOW BIRTH WEIGHT;

EID: 0033947530     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.1999.0006     Document Type: Article

References (61)

1. Northway WHJ, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med. 276:1967;357-368.
2. Koumbourlis AC, Motoyama EK, Mutich RL, Mallory GB, Walczak SA, Fertal K. Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease. Pediatric Pulmonology. 21:1996;28-34.
3. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 82:1988;527-532.
4. Kinali M, Greenough A, Dimitriou G, Yuksel B. Chronic respiratory morbidity following premature delivery - prediction of prolonged respiratory support requirement. Eur J Pediatrics. 158:1999;493-496.
5. Palta M, Sadek M, Barnet JH. Evaluation of criteria for chronic lung disease in surviving very low birthweight infants. J Pediatrics. 132:1998;57-63.
6. Greenough A, Kavvadia K, Johnson AH, Calvert S, Peacock J, Karani J. A simple chest radiograph score to predict chronic lung disease in prematurely born infants. Br J Radiology. 72:1999;1-4.
7. Fanaroff AA, Wright LL, Stevenson DK. Very low birthweight outcomes of the National Institute of Child Health and Human Developmental Neonatal Research Network May 1991 through December 1992. Am J Obst Gynecol. 173:1995;1423-1431.
8. Garland JS, Buck RK, Allred EN, Leviton A. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Arch Pediatr Adolesc Med. 149:1995;617-622.
9. Gonzalez A, Sosenko IRS, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 g or less. J Pediatr. 128:1996;470-478.
10. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr. 126:1995;605-610.
11. Tammela OKT. Appropriate fluid regimens to prevent bronchopulmonary dysplasia. Eur J Pediatr. 154:1995;S15-S18.
12. Kavvadia V, Greenough A, Dimitriou G, Hooper R. Comparison of the effect of two fluid input regimens on perinatal lung function of ventilated VLBW infants. Eur J Pediatr. 158:1999;917-922.
13. Greenough, A, Kavvadia, V, Dimitriou, G, Hooper, R, Randomized trial of fluid restriction in ventilated very low birthweight infants, Arch Dischild.
14. Hallman M, Pitknen, Rauvala H, Merritt TA. Glycolipid accumulation in lung effluent in bronchopulmonary dysplasia. Pediatr Res. 21:1987;454A.
15. Coalson JJ, King RJ, Yang F. SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. Am J Respir Crit Care Med. 151:1995;854-866.
16. Hagan R, Minutillo C, French N, Reese A, Landau L, LeSouef P. Neonatal chronic lung disease, oxygen dependency and a family history of asthma. Pediatr Pulmonol. 20:1995;277-283.
17. Ozdemir A, Brown MA, Morgan WJ. Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol. 23:1997;292-306.
18. Greenough A, Giffin FJ, Yüksel B, Dimitriou G. Respiratory morbidity in young school children born prematurely - chronic lung disease is not a risk factor. Eur J Pediatr. 155:1996;823-826.
19. Elder DE, Hagan R, Evans SF, Benninger HR, French NP. Recurrent wheezing in very preterm infants. Arch Dis Childhood. 74:1996;F165-F171.
20. Greenough A, Giffin FJ, Yüksel B. Respiratory morbidity in preschool children born prematurely and its relationship to adverse neonatal events. Acta Paediatrica. 85:1996;772-777.
21. Schaubel D, Johansen H, Dutta M, Desmeules M, Becker A, Mao Y. Neonatal characteristics as risk factors for preschool asthma. J Asthma. 33:1996;255-264.
22. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med. 158:1998;1091-1095.
23. Giffin F, Greenough A, Yuksel B. Does the duration of oxygen dependence after birth influence subsequent respiratory morbidity. Eur J Pediatr. 153:1994;34-37.
24. Rona RJ, Gulliford MC, Chinn S. Effects of prematurity and intrauterine growth on respiratory health and lung function in childhood. Br Med J. 306:1993;817-820.
25. Chan KN, Elliman A, Bryan E, Silverman M. Respiratory symptoms in children of low birthweight. Arch Dis Childhood. 64:1989;1294.
26. McLeod A, Ross P, Mitchell S. Respiratory health in a total very low birthweight cohort and their classroom controls. Arch Dis Childhood. 74:1996;188-194.
27. Kelly YJ, Brabin BJ, Milligan P, Heaf DP, Reid J, Pearson MG. Maternal asthma, premature birth and the risk of respiratory morbidity in school children in Mersey. Thorax. 50:1995;525-530.
28. Alho O, Koivu M, Hartikainen-Sorri AL, Sorri M, Kilkku O, Rantakallio P. Is a child's history of acute otitis media and respiratory infection already determined in the antenatal and prenatal period. Int J Pediatr Otorhinolaryngol. 19:1990;129-137.
29. von Mutius E, Nicolai T, Martinez FD. Prematurity as a risk factor for asthma in preadolescent children. J Pediatr. 123:1993;223-229.
30. Gregoire M-C, Lefebvre F, Glorieux J. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia. Pediatrics. 101:1998;856-860.
31. Furman L, Baley J, Borawski-Clark E, Aucott S, Hack M. Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease. J Pediatr. 128:1996;447-452.
32. Yeo CL, Gray PH. Inguinal hernia in extremely preterm infants. J Paediatr Child Health. 30:1994;412-413.
33. Koops BL, Abman SH, Accurso FJ. Outpatient management and follow-up of bronchopulmonary dysplasia. Clin Perinatology. 11:1984;100-122.
34. Sauve RS, Singhal N. Long term morbidity of infants with bronchopulmonary dysplasia. Pediatrics. 76:1985;725-733.
35. Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 82:1988;199-203.
36. Meert K, Heidemann S, Lieh-lai M, Sarnaik AP. Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol. 7:1989;167-170.
37. Hall CB, Douglas RG, German JM, Messner MK. Nosocomial respiratory syncytial virus infection. N Engl J Med. 293:1975;1343-1436.
38. Kang JO, Kim CR. Nosocomial respiratory syncytial virus infection in a newborn nursery. J Korean Med Sci. 12:1997;489-491.
39. Yüksel B, Greenough A. Acute deteriorations in neonatal chronic lung disease. Eur J Pediatr. 151:1992;697-700.
40. Yüksel B, Greenough A. Viral infections acquired on the neonatal unit and lung function of preterm infants at follow-up. Acta Paediatrica. 83:1994;117-118.
41. Giffin FJ, Greenough A, Yüksel B. Antiviral therapy in neonatal chronic lung disease. Early Hum Dev. 42:1995;97-109.
42. Thompson PJ, Greenough A. Hyperinflation in preterm infants at pre-school age. Acta Paediatrica. 81:1992;307-310.
43. Yüksel B, Greenough A, Maconochie I. Effective bronchodilator therapy by a simple spacer device for wheezy premature infants in the first two years of life. Arch Dis Child. 65:1990;782-785.
44. Yüksel B, Greenough A. Ipratropium bromide for symptomatic preterm infants. Eur J Pediatr. 150:1991;854-857.
45. Yüksel B, Greenough A. Relationship of symptoms to lung function abnormalities in preterm infants at follow-up. Pediatr Pulmonol. 11:1991;202-206.
46. Doyle LW, Ford GW, Olinsky A, Knoches A, Callanan C. Bronchopulmonary dysplasia and very low birthweight: lung function at 11 years of age. J Paediatr Child Health. 32:1996;339-343.
47. Bader D, Ramos AD, Law CD, Platzker ACG, Stabile MW, Keens TG. Childhood sequelae of infant lung function disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia. J Pediatr. 110:1987;693-699.
48. Margraf LR, Tomashefski JF, Bruce MC, Dahms BB. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis. 143:1991;391-400.
49. Cano A, Payo F. Lung function and airway responsiveness in children and adolescents after hyaline membrane disease: a matched cohort study. Eur Respir J. 10:1997;880-885.
50. Greenough A. Gains and losses from dexamethasone for neonatal chronic lung disease. Lancet. 352:1998;835-836.
51. Seidman DS, Laor A, Gale R, Stevenson DK, Danon YL. Is low birthweight a risk factor for asthma during adolescence. Arch Dis Child. 66:1991;584-587.
52. Matthes JW, Lewis PA, Davies DP, Bethel JA. Birth weight at term and lung function in adolescence: no evidence for a programmed effect. Arch Dis Child. 73:1995;231-234.
53. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birthweight and childhood respiratory infection to adult lung function and death from chronic obstructive airway disease. Br Med J. 303:1991;671-675.
54. Schraeder BD, Czajka C, Kalman DD, McGeady SJ. Respiratory health, lung function and airway responsiveness in school age survivors of very low birthweight. Clin Pediatr. 37:1998;237-245.
55. Bhuta T, Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonat Ed. 79:1998;F26-F33.
56. Vrlenich LA, Bozynski MEA, Shyr Y, Schork A, Roloff DW, McCormick MC. The effect of bronchopulmonary dysplasia on growth at school age. Pediatr. 95:1995;855-859.
57. Robertson CMT, Etches PC, Goldson E, Kyle JM. Eight-year school performance, neurodevelopmental and growth outcome of neonates with bronchopulmonary dysplasia: a comparative study. Pediatr. 89:1992;365-372.
58. Northway WH, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT, Eichler I, Lamm RL. Late pulmonary sequelae of bronchopulmonary dysplasia. New Engl J Med. 323:1990;1795-1799.
59. Davidson S, Schrayer A, Weilunsky E, Krikler R, Lilos P, Reisner SH. Energy intake, growth and development in ventilated, very low birthweight infants with and without bronchopulmonary dyplasia. Am J Dis Children. 144:1990;553-559.
60. Wheater M, Rennie JM. Poor prognosis after prolonged ventilation for bronchopulmonary dysplasia. Arch Dis Child. 71:1994;F210-F211.
61. Bozynski ME, Nelson MN, Matalon TA. Prolonged mechanical ventilation and intracranial hemorrhage: impact on developmental progress through 18 months in infants weighing 1,200 grams or less at birth. Pediatr. 79:1987;670-675.